N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]icosa-5,8,11,14,17-pentaenamide (199875-71-3)
| Identification |
| Properties |
| Safety Data |
| |
 |
Other Product
- Undecanamide,11-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]-N-[11-[[2-(1H-indol-3-yl)ethyl]amino]-11-oxoundecyl]-
- Docosanamide,N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-
- Eicosanamide,N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-
- Acetamide,N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-
- Benzamide, N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-
- N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]tetracosanamide
- Adenosine, N-(2-(5-hydroxy-1H-indol-3-yl)ethyl)-
- Benzeneacetamide, N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-
- Undecanamide,11-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]-N-[2-(1H-indol-3-yl)ethyl]-
- 2(1H)-Pyridinone,5-[(3â,5â,14â,17â)-3,14- dihydroxyandrostan-17-yl]-
- 1/C14H9Br2O2P/c15-11-6-8-13(17-11)19(10-4-2-1-3-5-10)14-9-7-12(16)18-14/h1-9
- 1/C14H15O3P/c15-18(16-11-13-7-3-1-4-8-13)17-12-14-9-5-2-6-10-14/h1-10,18H,11-12H
- 1/C15H22O3/c1-9-10(2)14-12(11(3)13(9)17)5-6-15(4,18-14)7-8-16/h16-17H,5-8H2,1-4H
- 1/C15H13NO/c1-2-16-14-6-4-3-5-12(14)13-9-11(10-17)7-8-15(13)16/h3-10H,2H2,1H
- 1/C14H19NO2/c1-3-12-10-17-9-8-15(12)14-7-5-4-6-13(14)11(2)16/h4-7,12H,3,8-10H2,1-2H
- Benzeneacetamide,5-azido-N-[(5a)-4,5-epoxy-3-hydroxy-17-methyl-6-oxomorphinan-14-yl]-2-nitro-(9CI)
- Tetracosanamide,N-[2-(5-hydroxy-1H-indol- 3-yl)ethyl]-,mixt. with N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]- docosanamide
- Docosanamide, 22-hydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-
- 1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
- 1/C12H10N4O3/c1-3-19-12(18)10-9(7(2)17)6-14-11-8(4-13)5-15-16(10)11/h5-6H,3H2,1-2H
